WallStreetZenWallStreetZen

NASDAQ: IRTC
Irhythm Technologies Inc Stock

$88.94+0.90 (+1.02%)
Updated May 24, 2024
IRTC Price
$88.94
Fair Value Price
-$76.47
Market Cap
$2.77B
52 Week Low
$70.24
52 Week High
$124.80
P/E
-21.03x
P/B
30.64x
P/S
7.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$513.17M
Earnings
-$129.96M
Gross Margin
67%
Operating Margin
-24.11%
Profit Margin
-25.3%
Debt to Equity
9.08
Operating Cash Flow
-$71M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IRTC Overview

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IRTC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IRTC ($88.94) is overvalued by 216.31% relative to our estimate of its Fair Value price of -$76.47 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IRTC ($88.94) is not significantly undervalued (216.31%) relative to our estimate of its Fair Value price of -$76.47 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IRTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IRTC due diligence checks available for Premium users.

Be the first to know about important IRTC news, forecast changes, insider trades & much more!

IRTC News

Valuation

IRTC fair value

Fair Value of IRTC stock based on Discounted Cash Flow (DCF)
Price
$88.94
Fair Value
-$76.47
Undervalued by
216.31%
IRTC ($88.94) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IRTC ($88.94) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IRTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IRTC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-21.03x
Industry
30.23x
Market
32.03x

IRTC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
30.64x
Industry
3.95x
IRTC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IRTC's financial health

Profit margin

Revenue
$131.9M
Net Income
-$45.7M
Profit Margin
-34.6%
IRTC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
IRTC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$909.8M
Liabilities
$819.5M
Debt to equity
9.08
IRTC's short-term assets ($687.46M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IRTC's long-term liabilities ($722.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IRTC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IRTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$52.0M
Investing
$40.0M
Financing
$504.6M
IRTC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IRTC vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
IRTC$2.77B+1.02%-21.03x30.64x
QDEL$2.84B+1.31%-1.61x0.86x
NARI$2.90B+5.29%-124.88x6.49x
NVCR$2.49B+3.77%-12.86x6.93x
LIVN$3.23B+0.37%-101.02x2.64x

Irhythm Technologies Stock FAQ

What is Irhythm Technologies's quote symbol?

(NASDAQ: IRTC) Irhythm Technologies trades on the NASDAQ under the ticker symbol IRTC. Irhythm Technologies stock quotes can also be displayed as NASDAQ: IRTC.

If you're new to stock investing, here's how to buy Irhythm Technologies stock.

What is the 52 week high and low for Irhythm Technologies (NASDAQ: IRTC)?

(NASDAQ: IRTC) Irhythm Technologies's 52-week high was $124.80, and its 52-week low was $70.24. It is currently -28.73% from its 52-week high and 26.62% from its 52-week low.

How much is Irhythm Technologies stock worth today?

(NASDAQ: IRTC) Irhythm Technologies currently has 31,104,883 outstanding shares. With Irhythm Technologies stock trading at $88.94 per share, the total value of Irhythm Technologies stock (market capitalization) is $2.77B.

Irhythm Technologies stock was originally listed at a price of $26.05 in Oct 20, 2016. If you had invested in Irhythm Technologies stock at $26.05, your return over the last 7 years would have been 241.42%, for an annualized return of 19.17% (not including any dividends or dividend reinvestments).

How much is Irhythm Technologies's stock price per share?

(NASDAQ: IRTC) Irhythm Technologies stock price per share is $88.94 today (as of May 24, 2024).

What is Irhythm Technologies's Market Cap?

(NASDAQ: IRTC) Irhythm Technologies's market cap is $2.77B, as of May 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Irhythm Technologies's market cap is calculated by multiplying IRTC's current stock price of $88.94 by IRTC's total outstanding shares of 31,104,883.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.